Clinical presentation and time course in hypersensitivity reactions to β‐lactams
Abstract
Background: β‐lactam hypersensitivity reactions are classified as immediate or nonimmediate. Diagnosis is usually based upon skin tests and provocation challenges.Objective: The time course of the reactions in proven β‐lactam hypersensitivities was studied and then correlated with the symptoms to determine the relationship between the clinical presentations and the time course.Method: All of the patients who consulted between 1996 and 2004 for a suspected β‐lactam hypersensitivity reaction were studied. Two hundred and ten patients with a proven hypersensitivity reaction diagnosed according to the European Network on Drug Allergy were included in the present study.Results: Of the patients, 36.7% had urticaria as a single symptom, 19.1% anaphylaxis without shock, 17.6% anaphylactic shock and 19.1% maculopapular exanthema. Anaphylactic shock and anaphylaxis mostly occurred within 1 h after drug administration. Exanthema mainly occurred after 24 h. Urticaria as a single symptom occurred at any time. A firm diagnosis was determined using immediate‐reading skin prick (10.0%) and intradermal tests (38.1%), late‐reading skin tests (19.1%) or provocation tests (32.9%).Conclusion and clinical implication: Depending on the time course of the reaction, three clinical groups were identified: anaphylaxis and anaphylactic shock (immediate reaction); maculopapular exanthema (late reaction) as well as urticaria (immediate and late reaction).Keywords
This publication has 33 references indexed in Scilit:
- Cross-reactivity among drugs: clinical problemsToxicology, 2005
- Specificities of B cell reactions to drugsToxicology, 2005
- T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory ActivityPLOS Medicine, 2005
- Delayed hypersensitivity to cefazolin: report on a case involving lymphocyte transformation studies with different cephalosporinsAnnals of Allergy, Asthma & Immunology, 2001
- HIV and drug allergyCurrent Opinion in Allergy and Clinical Immunology, 2001
- Penicillins and cephalosporins as allergens — structural aspects of recognition and cross‐reactionsClinical & Experimental Allergy, 1999
- Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to catsJournal of Allergy and Clinical Immunology, 1998
- Effects of peptide therapy on ex vivo T-cell responsesJournal of Allergy and Clinical Immunology, 1998
- Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patientsAllergy, 1996
- Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patientsAllergy, 1996